RBTT-11. NRG ONCOLOGY NRG-BN006: A PHASE II/III RANDOMIZED, OPEN-LABEL STUDY OF TOCA 511 AND TOCA FC WITH STANDARD OF CARE COMPARED TO STANDARD OF CARE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA Article

Ahluwalia, Manmeet, Pugh, Stephanie, Ellingson, Benjamin et al. (2019). RBTT-11. NRG ONCOLOGY NRG-BN006: A PHASE II/III RANDOMIZED, OPEN-LABEL STUDY OF TOCA 511 AND TOCA FC WITH STANDARD OF CARE COMPARED TO STANDARD OF CARE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA . NEURO-ONCOLOGY, 21(Supplement_6), vi220-vi221. 10.1093/neuonc/noz175.922

cited authors

  • Ahluwalia, Manmeet; Pugh, Stephanie; Ellingson, Benjamin; Kotecha, Rupesh; Cloughesy, Timothy; Vogelbaum, Michael; Aldape, Kenneth; Cui, Yunfeng; Armstrong, Terri; Mehta, Minesh

authors

publication date

  • November 11, 2019

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3204 Immunology
  • 3211 Oncology and Carcinogenesis
  • 6 Evaluation of treatments and therapeutic interventions
  • 6.1 Pharmaceuticals
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Genetics
  • Human Genome
  • Immunotherapy
  • Orphan Drug
  • Patient Safety
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • Oxford University Press (OUP)

start page

  • vi220

end page

  • vi221

volume

  • 21

issue

  • Supplement_6